Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chromosome 7 abnormalities are common in chordomas.

Petter Brandal1, Bodil Bjerkehagen, Håvard Danielsen

  • 1Department of Cancer Genetics, The Norwegian Radium Hospital, Montebello, Oslo 0310, Norway.

Cancer Genetics and Cytogenetics
|June 14, 2005
PubMed
Summary

Chordomas are rare bone cancers. This study reveals complex genetic changes in sacral chordomas, including gains in chromosome 7 and losses in chromosome 9, impacting patient survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The European Association for Neuro-oncology (EANO) Consensus Statement on Radiation Necrosis.

Neuro-oncology·2026
Same author

Radiotherapy quality assurance in the PRO-GLIO trial: results from a dummy run comparing experts across twelve institutions in two Scandinavian countries.

Clinical and translational radiation oncology·2026
Same author

Spatial-temporal recurrence patterns of grade 4 glioma using deep learning integrated multiparametric MRI and molecular pathology.

NPJ precision oncology·2026
Same author

Case Report: Proton beam therapy - friend or foe for patients with <i>IDH</i>-mutated WHO grade 2 and 3 gliomas?

Frontiers in oncology·2026
Same author

European neuro-oncology quality assessment (ENOQUA): A European organization for the research and treatment of cancer (EORTC) brain tumor group research project.

Neuro-oncology practice·2026
Same author

Unexpected frequency of radiation induced contrast enhancement after proton radiotherapy in glioma patients treated within the Swedish PRO-CNS study.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Chordomas are malignant bone tumors primarily affecting the axial skeleton.
  • Survival rates for chordoma patients range from 50-80% over five years.
  • The complex cytogenetic and molecular genetic landscape of chordomas remains largely undefined.

Purpose of the Study:

  • To investigate the molecular cytogenetic features of six sacral chordoma tumors.
  • To provide further insights into the genetic alterations underlying chordoma development.

Main Methods:

  • Comparative Genomic Hybridization (CGH) was employed to detect chromosomal copy number variations.
  • Interphase fluorescence in situ hybridization (IP-FISH) was utilized to confirm CGH findings and analyze chromosome polysomy.

Related Experiment Videos

Main Results:

  • CGH analysis identified frequent gains in chromosomal regions 1q23–q24, 7p21–p22, 7q, and 19p13, and loss in 9p22–p23.
  • IP-FISH confirmed CGH results and revealed chromosome 7 polysomy in four tumors, with some exhibiting pentasomic clones.
  • Observed genetic imbalances were largely consistent with prior CGH studies, with notable differences in the frequency of 1p and 3p alterations.

Conclusions:

  • Sacral chordomas exhibit distinct chromosomal imbalances, particularly gains involving chromosome 7.
  • The polysomy of chromosome 7 is a recurrent finding in chordomas.
  • These genetic alterations may contribute to the complex nature and progression of chordoma.